PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study
大型临床试验中患者报告结局(PRO)与临床医生报告的不良事件:POLARIX 3期研究结果
期刊:Blood
影响因子:
doi:10.1182/blood.2025028848
Thompson, Carrie; Trněný, Marek; Morschhauser, Franck; Salles, Gilles; Reagan, Patrick M; Hertzberg, Mark; Zhang, Huilai; Thieblemont, Catherine; Hu, Bei; Fonseca, Gustavo; Kim, Won Seog; Martelli, Maurizio; Mehta, Amitkumar; Singh, Avrita; Yan, Mark; Hirata, Jamie; Sugidono, Matthew; Lee, Calvin; Sharman, Jeff P; Mehta-Shah, Neha; Flowers, Christopher R; Tilly, Hervé; Chua, Neil; Casasnovas, René-Olivier; Miall, Fiona; Kim, Tae Min; Tsai, Xavier Cheng-Hong; Nasta, Sunita; Lee, Seung Tae; Friedberg, Jonathan W